Current data indicate that there is a significant risk of endometrial cancer (EC) in women with
polycystic ovarian syndrome (PCOS), although further research needed to clarify the exact …

The underlying mechanisms of polycystic ovarian syndrome (PCOS)-induced endometrial
dysfunction are not fully understood, and although accumulating evidence shows that the …

Background Endometrial cancer (EC) is the most common gynaecological cancer amongst
women in the UK. Although previous studies have found that women with polycystic ovary …

Endometrial cancer (EC) is a common gynecological cancer that endangers women health.
Although substantial progresses of EC management have been achieved in recent years …

Although a number of in vitro studies have demonstrated the antiproliferative, anti-invasive,
and antimetastatic effects of metformin in multiple cancer cell types, its cellular and …

Background We examined the distribution of obesity, diabetes, and race in Type I and Type
II endometrial cancers (EC) and their associations with clinical outcomes. Methods A multi …

Background Cardiovascular disease is a major cause of death in endometrial cancer
survivors. The aim of this study was to determine whether women newly diagnosed with …

Background: Young women with polycystic ovary syndrome (PCOS) have a high risk of
developing endometrial carcinoma. There is a need for the development of new medical …

Simple Summary Insulin resistance is one of the risk factors of endometrial cancer.
Hyperinsulinemia can trigger many physiological effects that drive carcinogenesis, which is …

Objective Metformin reduces cancer incidence and improves overall survival in diabetic
patients. In preclinical studies, metformin decreases endometrial cancer (EC) cell growth by …